Insiders Kura Oncology, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 09/05/2024 BST			5-day change	1st Jan Change
20.77 ^USD	+1.10%		+0.87%	+44.44%

05-02	Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024
05-02	Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Kura Oncology Appoints Brian Powl as Chief Commercial Officer	14/08/23	CI
Insider Sell: Kura Oncology	31/01/23	MT
Kirsten Flowers Notifies Kura Oncology, Inc. of Resignation as Chief Commercial Officer	13/01/23	CI
Alector Appoints Marc Grasso as CFO	07/02/22	MT
Kura Oncology Finance Chief Marc Grasso to Step Down	02/02/22	MT
Kura Oncology, Inc. Announces Executive Changes	01/02/22	CI
Kura Oncology, Inc. Appoints Teresa Bair as Chief Legal Officer	18/10/21	CI
Kura Oncology, Inc. Appoints Helen Collins, M.D. as Class II Director to its Board of Directors	29/07/21	CI
Kura Oncology, Inc. Announce Resignation of Robert E. Hoffman as Member of the Board of Directors	04/06/21	CI
Kura Oncology, Inc. Appoints Carol Schafer to its Board of Directors	04/06/21	CI
Kura Oncology, Inc. Announces Management Changes	25/08/20	CI
Kura Oncology, Inc. Announces Executive Changes, Effective on February 7, 2020	23/01/20	CI
Kura Oncology, Inc. Appoints Kirsten Flowers as Chief Commercial Officer	06/01/20	CI
Kura Oncology, Inc. Appoints James Basta as Chief Legal Officer, Corporate Secretary and Chief Compliance Officer	04/11/19	CI
Kura Oncology, Inc. Appoints Diane Parks to its Board of Directors	15/10/19	CI
Kura Oncology, Inc. Announces Executive Changes	12/08/19	CI
Kura Oncology, Inc. Appoints Mary Szela to its Board of Directors	08/11/18	CI
Kura Oncology, Inc. Announces Executive Changes	31/07/18	CI
Kura Oncology Announces Executive Changes	20/06/18	CI
Kura Oncology, Inc. Announces Executive Changes	11/06/18	CI

No results for this search